HUB services have been around for about a decade now. In the past, pharma companies were beginning to recognize that there was more involved in bringing new drugs to the market than just getting the dosages into distribution channels.
In addition to more common concerns, pharma was experiencing more and more restrictions from payers. Particularly, from the Prior Authorization (PA) form. This was very time-consuming and had to be filled out ahead of time by the prescriber.
Therefore, the HUBs focused more on reimbursement and prescriber support. Initially run in-house, as the use of HUBs broadened "prescriber support" to "patient support," third-party HUB service providers began to enter the market.
To date, this vertical industry shows no sign of slowing growth.
Whether you’re knowledgeable on Clinical Trials and the process that goes into it or not, it's correctly assumed that the work is far from light. There are four phases for each study conducted that tells the plot of the story, but doesn’t dive into the supporting elements within.
A key component of any company is sales. The product or service must be sold in order for the business to continue running their business.
Pharmaceutical companies aren't immune to this requirement. This is why they run advertisements online, on the radio, on billboards, and on television. Yet, it's not only individuals with conditions and diseases that they need to expose their product to.
Pharmaceutical companies also need to convince doctors that their drugs work and could be beneficial to patients. It's for this reason that pharmaceutical representatives are sent out into the field, to speak with healthcare officials, and showcase the newest drug developments.
Driving pharma to the cloud is value-driven and geared to patients who take active roles in their healthcare. Specifically, those who want information at their fingertips. Instead, of waiting for it to trickle down through the maze of doctors, tests, and procedures.
It's also driven by constantly changing health care regulations, finances, digital initiation, integration, and individual companies that want more efficient ways to manage their patient data.
Will public clouds be too risky? Will private clouds be safe? What about a hybrid of the two?
While you're analyzing the risks and benefits that the cloud might bring to your organization, consider the network availability. Performance and security are key players in those driving forces that help enterprises choose a cloud infrastructure.
You can say it's the season for getting into awkward conversations with people you probably haven't seen since the last holiday gathering. While it's difficult to predict the array of questions you'll be asked, one question you're certain to hear a few times is, "So, what is it that you do again?"
Of course, you can just answer pharmaceutical sales management and let that be the end of it. Or, you could use the opportunity to evangelize that one specific role that has you excited to go to work each day: Sales operations.
The emergence of big data, technological advancements and data science approaches has dramatically transformed industries like retail, finance, and travel.
The Life Sciences industry is no exception.
Companies in the Life Sciences industry have a high-volume of unorganized data sets they aren't aware of that contains hidden actionable insights.
The life sciences industry hasn't fully adapted to new technologies but they've gotten off to a convincing start.
Still, a huge number of enterprises haven't been able to decode the insights because of lack of expertise in pharma data analytics and inefficient pharma master data management.
Avirup Basu | June 7, 2018
Anupam Nandwana | January 9, 2018
Anupam Nandwana | October 6, 2017
Anupam Nandwana | February 8, 2017
Anupam Nandwana | January 5, 2018